SCHEMBL2903422

SCHEMBL2903422

Cc1cc(CNc2nn3c(C(=O)O)cnc3cc2C)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 4/20 0.43
MMP10 P09238 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
PPARA Q07869 3/20 0.37
HDAC3 O15379 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
VNN1 O95497 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
CTNNB1 P35222 1/20 0.36
TCF7L2 Q9NQB0 1/20 0.36
CHRM4 P08173 1/20 0.36
P4HTM Q9NXG6 1/20 0.36
NTRK1 P04629 3/20 0.35
FYN P06241 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905633 0.91 HDAC3 (0.46) HDAC3HDAC1HDAC2FYNHDAC6
SCHEMBL1202935 0.89 P4HTM (0.47) PPARAP4HTMFYN
SCHEMBL2905868 0.85 FYN (0.50) MMP13NTRK1FYN
SCHEMBL1204006 0.85 CTNNB1 (0.41) MMP13MMP10MMP8CTNNB1TCF7L2
SCHEMBL2903393 0.83 KDM4E (0.47) PPARAVNN1CHRM4FYN
SCHEMBL1203133 0.79 DDR2 (0.47) CTNNB1TCF7L2NTRK1
SCHEMBL2907129 0.78 HDAC3 (0.44) HDAC3HDAC1HDAC2VNN1NTRK1
SCHEMBL1202030 0.77 ALDH1A1 (0.44) CTNNB1TCF7L2P4HTM
SCHEMBL1203676 0.77 HDAC3 (0.43) HDAC3HDAC1HDAC2CTNNB1TCF7L2
SCHEMBL1203106 0.75 NTRK1 (0.49) NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217601-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) 2010-08-18 EP disclosed
WO-2009060197-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2009-05-14 WO disclosed